Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services will host a March 1 call for stakeholders on its recent request for information on barriers to accessing health care coverage and services through Medicaid and the Children鈥檚 Health Insurance Program.
The Cybersecurity and Infrastructure Security Agency and FBI Saturday urged U.S. organizations to take steps to detect and protect against two malware threats used against organizations in Ukraine that can destroy computer systems and render them inoperable. One, known as WhisperGate and鈥
In Part 2 of AHA鈥檚 special podcast series featuring guests from the organization鈥檚 most-downloaded podcasts, Elisa Arespacochaga, AHA鈥檚 vice president of clinical affairs and workforce, talks with Brooke Buckley, chief medical officer of Henry Ford Wyandotte Hospital, and Harsh Trivedi, M.D.,鈥
The Food and Drug Administration authorized a revised dosing regimen for the combination monoclonal antibody therapy Evusheld when used to prevent COVID-19 in certain patients, citing data showing a higher initial dose may better prevent infection by certain omicron subvariants.
The Center for Medicare & Medicaid Innovation announced a redesign of the Global and Professional Direct Contracting Model, which launched last year and was supposed to continue through 2026.
Sens. Dick Durbin, D-Ill., and Rob Portman, R-Ohio, introduced the Senate companion to the Post-Disaster Mental Health Response Act (S. 3677), AHA-supported legislation that would expand the Federal Emergency Management Agency鈥檚 Crisis Counseling Assistance and Training Program to federally-鈥
The Agency for Health Care Research and Quality named as its new director Robert 鈥淏ob鈥 Otto Valdez, Robert Wood Johnson Foundation professor emeritus of family and community medicine and economics at the University of New Mexico.
Million Hearts 2027 is a national initiative to prevent one million heart attacks, strokes, and other cardiovascular events over the next five years.
The Centers for Disease Control and Prevention said some people may wish to receive their second dose of the Pfizer or Moderna COVID-19 vaccine up to eight weeks after the first, especially males aged 12 to 39.
The AHA recommended hospitals and health systems take certain immediate steps to protect against increased cyber risks to the U.S. health system stemming from the ongoing military operations in the Russia/Ukraine region.